サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1760989

核医学放射性同位元素の世界市場

Nuclear Medicine Radioisotope

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
核医学放射性同位元素の世界市場
出版日: 2025年07月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

核医学放射性同位元素の世界市場は2030年までに166億米ドルに到達

2024年に106億米ドルと推定される核医学放射性同位元素の世界市場は、2030年には166億米ドルに達し、分析期間2024-2030年のCAGRは7.8%で成長すると予測されます。本レポートで分析したセグメントの1つであるテクネチウム-99m（Tc-99m）は、CAGR 8.7％を記録し、分析期間終了までに117億米ドルに達すると予測されます。タリウム-201（Tl-201）セグメントの成長率は、分析期間中CAGR6.2％と推定されます。

米国市場は30億米ドルと推定、中国はCAGR7.1%で成長予測

米国の核医学放射性同位元素市場は2024年に30億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに25億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.4％と6.2％と予測されています。欧州では、ドイツがCAGR約6.2%で成長すると予測されています。

世界の核医学放射性同位元素市場- 主要動向と促進要因まとめ

核医学放射性同位元素とは何か、なぜ重要なのか？

核医学放射性同位元素は、主に腫瘍学、心臓病学、神経学の分野で、画像診断や治療で使用される放射性物質です。これらのアイソトープは放射線を放出し、医師が臓器、組織、骨の詳細な画像を撮影することを可能にし、がん、心臓病、アルツハイマー病などの病気の発見に役立ちます。一般的な放射性同位元素には、画像診断用のテクネチウム99m（Tc-99m）や甲状腺がんの治療用のヨウ素131などがあります。放射性同位元素は、PETやSPECTスキャンなどの非侵襲的イメージング技術を可能にし、手術を必要としない高精度の診断を提供するため、核医学において重要な役割を果たしています。放射性医薬品のような治療への応用は、健康な組織へのダメージを最小限に抑える標的治療を可能にし、患者の転帰を向上させる。

技術革新はどのように核医学放射性同位元素市場を形成しているか？

放射性医薬品とアイソトープ製造における技術進歩が、核医学放射性同位元素市場を大きく形成しています。先進サイクロトロンと原子炉の開発により、放射性同位元素生産の効率と安全性が向上しました。さらに、原子炉に関連するリスクを軽減し、安定供給を確保しようとするヘルスケアシステムに伴い、原子炉を使用しないテクネチウム-99mの生成など、代替製造方法の調査が活発化しています。また、放射性医薬品製剤の進歩により、放射性同位元素の標的をより正確に特定できるようになり、診断精度と治療効果の両方が向上しています。さらに、人工知能（AI）を核医学に組み込んで画像解析を改善し、臨床医がより迅速で正確な診断を行えるようにしています。

疾病パターンの変化と消費者行動は放射性同位元素の需要にどのような影響を与えているか？

慢性疾患、特にがんと心血管疾患の有病率の増加が、核医学放射性同位元素の世界の需要を牽引しています。がんの診断が世界中で増加する中、放射性同位元素は早期発見と標的治療の両方において重要な役割を果たしています。患者やヘルスケアプロバイダーが非侵襲的な診断ツールや個別化された治療計画をますます優先するようになり、消費者行動も市場に影響を与えています。先進医療技術へのアクセスが拡大している地域では、核医学が標準的なヘルスケア診療に組み込まれつつあります。さらに、世界の高齢化により、認知症や退行性心疾患などの加齢関連疾患の診断と治療における核医学の需要が高まっています。核医学に対する患者の認識が高まるにつれ、高品質で即効性のある診断ソリューションに対する需要も高まっています。

核医学放射性同位元素市場の成長は複数の要因によってもたらされる

核医学放射性同位元素市場の成長は、技術の進歩、ヘルスケアニーズの進化、放射性医薬品の採用増加など、いくつかの要因によってもたらされます。サイクロトロン技術や放射性医薬品における技術革新により、放射性同位元素の安全性、精度、入手可能性が向上しており、医療用画像診断やがん治療への利用が拡大しています。がんや心血管障害などの慢性疾患の蔓延が、診断画像や治療用途の主要な推進力となっており、テクネチウム-99mやヨウ素131などの特定アイソトープの需要を押し上げています。さらに、個別化医療へのシフトは、より少ない副作用でより効果的な治療結果を提供する標的ラジオアイソトープ治療の使用を拡大しています。特に新興国市場で核医学インフラを支援する政府のイニシアティブや、病院におけるPETおよびSPECTスキャン装置の利用可能性の増加も市場開拓に大きく寄与しています。最後に、非リアクターベースのアイソトープ製造法の開発を含むサプライチェーンの改善により、医療用アイソトープの信頼性と持続可能性が高まり、市場の拡大にさらに拍車がかかっています。

セグメント

放射性同位元素の種類（テクネチウム-99m（Tc-99m）、タリウム-201（Tl-201）、ガリウム-67（Ga-67）、ヨウ素（I-123）、その他の放射性同位元素の種類）;用途（心臓病学、腫瘍学、神経学、リンパ腫、甲状腺、その他の用途）

調査対象企業の例（注目の42社）

  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • NTP Radioisotopes SOC Ltd.
  • Positron Corporation
  • Siemens Healthineers

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13634

Global Nuclear Medicine Radioisotope Market to Reach US$16.6 Billion by 2030

The global market for Nuclear Medicine Radioisotope estimated at US$10.6 Billion in the year 2024, is expected to reach US$16.6 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end of the analysis period. Growth in the Thallium-201 (Tl-201) segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 7.1% CAGR

The Nuclear Medicine Radioisotope market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Nuclear Medicine Radioisotope Market - Key Trends & Drivers Summarized

What Are Nuclear Medicine Radioisotopes and Why Are They Important?

Nuclear medicine radioisotopes are radioactive substances used in diagnostic imaging and therapeutic treatments, primarily in the field of oncology, cardiology, and neurology. These isotopes emit radiation that allows doctors to capture detailed images of organs, tissues, and bones, aiding in the detection of diseases such as cancer, heart disease, and Alzheimer’s. Common radioisotopes include Technetium-99m (Tc-99m) for diagnostic imaging and Iodine-131 for treating thyroid cancer. Radioisotopes play a critical role in nuclear medicine because they enable non-invasive imaging techniques, such as PET and SPECT scans, providing high-precision diagnostics without the need for surgery. Their therapeutic applications, such as radiopharmaceuticals, allow for targeted treatments that minimize damage to healthy tissue, enhancing patient outcomes.

How Are Technological Innovations Shaping the Nuclear Medicine Radioisotope Market?

Technological advancements in radiopharmacy and isotope production are significantly shaping the nuclear medicine radioisotope market. The development of advanced cyclotrons and nuclear reactors has improved the efficiency and safety of radioisotope production. Additionally, research into alternative production methods, such as non-reactor-based generation of Technetium-99m, is gaining momentum as healthcare systems seek to mitigate the risks associated with nuclear reactors and ensure a stable supply. Advancements in radiopharmaceutical formulations have also allowed for more precise targeting of radioisotopes, enhancing both the diagnostic accuracy and therapeutic efficacy of treatments. Furthermore, artificial intelligence (AI) is being integrated into nuclear medicine to improve image analysis, allowing clinicians to make faster and more accurate diagnoses.

How Are Changing Disease Patterns and Consumer Behavior Impacting Demand for Radioisotopes?

The increasing prevalence of chronic diseases, particularly cancer and cardiovascular conditions, is driving global demand for nuclear medicine radioisotopes. With cancer diagnoses rising worldwide, radioisotopes are playing a critical role in both early detection and targeted therapies. Consumer behavior is also influencing the market, as patients and healthcare providers increasingly prioritize non-invasive diagnostic tools and personalized treatment plans. In regions where access to advanced medical technologies is expanding, nuclear medicine is becoming more integrated into standard healthcare practices. Additionally, an aging global population is creating greater demand for nuclear medicine in the diagnosis and treatment of age-related diseases, such as dementia and degenerative heart conditions. As patient awareness of nuclear medicine grows, so does the demand for high-quality, fast-acting diagnostic solutions.

Growth in the Nuclear Medicine Radioisotope Market Is Driven by Several Factors

The growth in the nuclear medicine radioisotope market is driven by several factors, including technological advancements, evolving healthcare needs, and the increasing adoption of radiopharmaceuticals. Innovations in cyclotron technology and radiopharmaceuticals are improving the safety, precision, and availability of radioisotopes, which is encouraging wider use in medical imaging and cancer therapies. The growing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is a major driver for diagnostic imaging and therapeutic applications, pushing demand for specific isotopes like Technetium-99m and Iodine-131. Additionally, the shift toward personalized medicine is expanding the use of targeted radioisotope therapies, which offer more effective treatment outcomes with fewer side effects. Government initiatives supporting nuclear medicine infrastructure, particularly in developing regions, and the increasing availability of PET and SPECT scanning devices in hospitals are also significant contributors to market growth. Finally, supply chain improvements, including the development of non-reactor-based isotope production methods, are ensuring a more reliable and sustainable supply of medical isotopes, further fueling the market’s expansion.

SCOPE OF STUDY:

The report analyzes the Nuclear Medicine Radioisotope market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radioisotope Type (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123), Other Radioisotope Types); Application (Cardiology, Oncology, Neurology, Lymphoma, Thyroid, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • GE Healthcare
  • Hologic, Inc.
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • NTP Radioisotopes SOC Ltd.
  • Positron Corporation
  • Siemens Healthineers

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Nuclear Medicine Radioisotope - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Cancer and Cardiovascular Diseases Spurs Strong Growth in the Nuclear Medicine Radioisotope Market
    • Technological Innovations in Radiopharmaceuticals Expand the Addressable Market Opportunity for Nuclear Medicine Radioisotopes
    • Aging Population and Rising Life Expectancy Worldwide Strengthen the Business Case for Greater Utilization of Radioisotopes in Healthcare
    • Expansion of PET-CT and SPECT Imaging Technology Propels Growth in Diagnostic Applications for Nuclear Medicine
    • Government Healthcare Initiatives and Infrastructure Modernization Projects Drive the Adoption of Nuclear Medicine Radioisotopes
    • Rising Demand for Minimally Invasive Diagnostic and Therapeutic Techniques Generates New Opportunities for Radioisotope-Based Solutions
    • Continuous Advancements in Cyclotron and Reactor Technologies Sustain Long-Term Growth in Global Radioisotope Production
    • Development of Targeted Radiotherapy Expands the Scope and Effectiveness of Therapeutic Nuclear Medicine Radioisotopes
    • Increased Focus on Precision Medicine and Personalized Treatments Strengthens Demand for Nuclear Medicine Radioisotopes in Oncology
    • Rising Incidence of Neurological and Neurodegenerative Disorders Accelerates Demand for Diagnostic Radioisotopes in Brain Imaging
    • Stringent Regulatory Approvals, Safety Protocols, and Licensing Challenges Present Barriers to Market Growth for Nuclear Medicine Radioisotopes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nuclear Medicine Radioisotope Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nuclear Medicine Radioisotope by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Technetium-99m (Tc-99m) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Technetium-99m (Tc-99m) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Technetium-99m (Tc-99m) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Thallium-201 (Tl-201) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Thallium-201 (Tl-201) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Thallium-201 (Tl-201) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gallium-67 (Ga-67) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gallium-67 (Ga-67) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Gallium-67 (Ga-67) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Iodine (I-123) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Iodine (I-123) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Iodine (I-123) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Radioisotope Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Radioisotope Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Radioisotope Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Nuclear Medicine Radioisotope by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nuclear Medicine Radioisotope Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Nuclear Medicine Radioisotope by Radioisotope Type - Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Nuclear Medicine Radioisotope by Radioisotope Type - Percentage Breakdown of Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine (I-123) and Other Radioisotope Types for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Nuclear Medicine Radioisotope by Application - Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Nuclear Medicine Radioisotope by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, Neurology, Lymphoma, Thyroid and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION